| C33 | The cost effectiveness and optimal configuration of oral HIV self-test kit distribution in South Africa: a model analysis | E-poster | HIV self-testing |
| C33 | Impact of a combination HIV testing package on couples' HIV testing and female awareness of male partner HIV status among pregnant women in Lusaka, Zambia: A randomized trial | E-poster | HIV self-testing |
| C33 | Mexico must promote HIV self-testing: evidence from a survey of 11,000 Mexican MSM | E-poster | HIV self-testing |
| C32 | Adherence to the dapivirine vaginal ring and oral PrEP among adolescent girls and young women in Africa: interim results from the REACH study | Oral abstract session with live Q&A | Novel delivery systems (e.g., rings, implants, transdermal systems) |
| C32 | Three approaches to forecasting potential numbers of dapivirine ring users for HIV prevention among women in sub-Saharan Africa | E-poster | Novel delivery systems (e.g., rings, implants, transdermal systems) |
| C32 | Discreetness and pain avoidance as central drivers of preferred characteristics in an HIV prevention implant among women in Zimbabwe and South Africa | E-poster | Novel delivery systems (e.g., rings, implants, transdermal systems) |
| C32 | Next generation 3D-printed intravaginal rings for prevention of HIV and unplanned pregnancy | E-poster | Novel delivery systems (e.g., rings, implants, transdermal systems) |
| C32 | Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs | E-poster | Novel delivery systems (e.g., rings, implants, transdermal systems) |
| C31 | HIV-1 Env markers of prevention efficacy in HVTN 704/HPTN 085, the Antibody-Mediated Prevention (AMP) trial of broadly neutralizing antibody (bnAb) VRC01 in the Americas and Europe: genotypic sieve analysis | E-poster | Broadly neutralizing antibodies |
| C30 | Global and regional estimates for subtype-specific therapeutic and prophylactic HIV-1 vaccines | E-poster | Vaccines |